Stratasys and CollPlant joint development addresses .6B bioprinting market opportunity

Stratasys and CollPlant joint development addresses $2.6B bioprinting market opportunity

by Medical

Stratasys and CollPlant have announced plans to “transform healthcare with industrial scale bioprinting of tissues and organs.” To establish a method for bio-fabricating human tissues and organs utilizing CollPlant Biotechnologies’ rh-Collagen-based bioinks and Stratasys Ltd’s P3 technology-based bioprinter, the two companies have signed a cooperative development and commercialization agreement. The first project focuses on making a solution for CollPlant’s program for regenerative breast implants that can be used on an industrial scale.

First US Surgeries Successfully Utilize 3D Printed PEEK Spinal Implants

First US Surgeries Successfully Utilize 3D Printed PEEK Spinal Implants

by Medical

In a medical 3D printing breakthrough, the first US surgeries featuring a revolutionary spinal implant made from Evonik‘s VESTAKEEP® i4 3DF PEEK filament biomaterial were conducted earlier this month. Developed by Curiteva, a US-based technology firm, the implant has been approved by the US Food and Drug Administration and is the first-ever 3D printed, fully interconnected porous polyether ether ketone (PEEK) implant of its kind for commercial use.